Veterinary Medicines

Versiguard Rabies, Suspension for injection

Authorised
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Download as PDF

Product identification

Medicine name:
Versiguard Rabies, Suspension for injection
Versiguard Rabies vet, injeksjonsvæske, suspensjon
Active substance:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Target species:
  • Cat
  • Cattle
  • Pig
  • Sheep
  • Goat
  • Horse
  • Ferret
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    2.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        hour
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:
  • Glass Vial 1 x 1.0 Dose
  • Glass Vial 10 x 10.0 Dose
  • Glass Vial 10 x 1.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 05-3851
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0100/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 12/09/2023
Updated on: 14/09/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 12/09/2023
Updated on: 14/09/2023
Download